- Home
- ATAI vs SMTI Comparison
ATAI vs SMTI Comparison
Compare ATAI & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- SMTI
- Stock Information
- Founded
- ATAI 2018
- SMTI 1982
- Country
- ATAI Germany
- SMTI United States
- Employees
- ATAI N/A
- SMTI N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- SMTI Medical/Dental Instruments
- Sector
- ATAI Health Care
- SMTI Health Care
- Exchange
- ATAI Nasdaq
- SMTI Nasdaq
- Market Cap
- ATAI 444.7M
- SMTI 252.1M
- IPO Year
- ATAI 2021
- SMTI N/A
- Fundamental
- Price
- ATAI $2.72
- SMTI $28.87
- Analyst Decision
- ATAI Strong Buy
- SMTI Strong Buy
- Analyst Count
- ATAI 2
- SMTI 2
- Target Price
- ATAI $11.00
- SMTI $49.50
- AVG Volume (30 Days)
- ATAI 6.0M
- SMTI 51.5K
- Earning Date
- ATAI 08-12-2025
- SMTI 08-11-2025
- Dividend Yield
- ATAI N/A
- SMTI N/A
- EPS Growth
- ATAI N/A
- SMTI N/A
- EPS
- ATAI N/A
- SMTI N/A
- Revenue
- ATAI $1,863,000.00
- SMTI $91,569,883.00
- Revenue This Year
- ATAI $554.22
- SMTI $23.53
- Revenue Next Year
- ATAI N/A
- SMTI $5.93
- P/E Ratio
- ATAI N/A
- SMTI N/A
- Revenue Growth
- ATAI 572.56
- SMTI 34.65
- 52 Week Low
- ATAI $1.03
- SMTI $25.86
- 52 Week High
- ATAI $2.99
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- ATAI 61.97
- SMTI 46.78
- Support Level
- ATAI $2.53
- SMTI $28.83
- Resistance Level
- ATAI $2.79
- SMTI $30.94
- Average True Range (ATR)
- ATAI 0.21
- SMTI 1.07
- MACD
- ATAI 0.01
- SMTI 0.15
- Stochastic Oscillator
- ATAI 73.10
- SMTI 38.94
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.